Risk Assessment of COVID-19 on Patients with Chronic Kidney Diseases in Libya
Derna Universiry Journal of Medical Sciences · 20.06.2023 · 1 (1) · 147-157
DOI: 10.58987/nk5vpv84 ↗Kurz gefasst
Fachartikel in der Zeitschrift Derna Universiry Journal of Medical Sciences, online erschienen am 20.06.2023. Verfasst von Manal Abuagela und 12 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The Sars covid 19 virus is an extremely contagious disease that originated in Wuhan, China, in late 2019. Widespread panic over the news of the infectious disease quickly followed, and despite most countries inflicting lockdown restrictions, the virus spread nonetheless, reaching over 230 countries and territories as of October 2022. This study is to provide insight into managing CKD patients' with COVID-19, and to declare that the diseases’ outcome was affected by individual factors on Libyan CKD patients. Data of 635 CKD patients were collected from Al-Shatt Road Kidney Diseases Center in Tripoli, from January to September 2020. Statistical analysis was conducted to assess the risk of this pandemic on kidney patients and to evaluate the impact of several related factors: gender, age, and CKD associated diseases. The rate of mortality among CKD patients COVID infected was determined as well. The results of this study showed that 18.5% of CKD patients tested positive for COVID-19, while 81.5% tested negative. The highest number among CKD with COVID-19 were males 58.8% vs female 41.2%. Patients with hypertension and diabetes age >45 were more vulnerable to COVID-19 than other CKD patients. In additions, 74% of CKD patients developed diabetes after COVID 19 infection. The fatality rate of CKD- COVID 19 positive was significantly higher than CKD- COVID 19 negative (29.8 % vs 2.3%) and male’s mortality rate was significantly higher than females, p-value
Zitieren
APA
Abuagela, M., Essarbout, A., Elgusbi, E., Abdulwahed, E., Jerbi, R., Alwaseea, N., Ahmed, F., Alaqeli, E. A., Ashur, A. B., Magrahi, H. E., Mousa, A., Atia, A., & Mamlook, R. A. (2023). Risk Assessment of COVID-19 on Patients with Chronic Kidney Diseases in Libya. Derna Universiry Journal of Medical Sciences, 1(1), 147-157. https://doi.org/10.58987/nk5vpv84
Vancouver
Abuagela M, Essarbout A, Elgusbi E, Abdulwahed E, Jerbi R, Alwaseea N, et al. Risk Assessment of COVID-19 on Patients with Chronic Kidney Diseases in Libya. Derna Universiry Journal of Medical Sciences. 2023;1(1):147-157. doi:10.58987/nk5vpv84
BibTeX
@article{Abuagela2023,
author = {Abuagela, Manal and Essarbout, Amel and Elgusbi, Eman and Abdulwahed, Eman and Jerbi, Rehab and Alwaseea, Najia and Ahmed, Fawzia and Alaqeli, Eman Alaqeli and Ashur, Abir Ben and Magrahi, Hamida El and Mousa, Arij and Atia, Ahmed and Mamlook, Rabia Al},
title = {Risk Assessment of COVID-19 on Patients with Chronic Kidney Diseases in Libya},
journal = {Derna Universiry Journal of Medical Sciences},
year = {2023},
volume = {1},
number = {1},
pages = {147--157},
doi = {10.58987/nk5vpv84}
}
EUVIMED